Breckenridge announces final FDA approval for Everolimus tablets for oral suspension, AB-rated to AFINITOR DISPERZĀ®

Breckenridge Pharmaceutical, Inc.,-the U.S. subsidiary of Towa International that markets, distributes, and sells generic pharmaceuticals in the United States, – announced today that the Food and Drug Administration (FDA) has granted final approval of Everolimus Tablets for Oral Suspension (TFOS), 2mg, 3mg and 5mg, a generic version of AFINITOR DISPERZ® by Novartis Pharmaceuticals Corporation. The […]

Upstream M&A climbs to $105 billion in 2024

Activity falls in Q4, but interest in gas may help deals rebound Enverus Intelligence® Research (EIR), a subsidiary of Enverus, the most trusted energy-dedicated SaaS company that leverages generative AI across its solutions,is releasing its summary of Q4 and full-year 2024 upstream M&A activity. The year closed with $105 billion in U.S. upstream deals, the

Archway Home Remodeling Elevates Chicago Homes with Exceptional Renovations and Craftsmanship

Chicago, IL – Archway Home Remodeling offers expert home renovation services tailored to meet the diverse needs of Chicago-area homeowners. With a history dating back to 1989, the company has become a trusted partner for those looking to enhance their homes with precision and artistry. As an established home remodeling contractor, Archway Home Remodeling delivers

Beco Air and Heat: Leading HVAC Contractor in Aledo Delivering Reliable Heating and Cooling Services Backed by Decades of Experience

Aledo, TX – Beco Air and Heat has been a reliable name in the HVAC industry since 1974. With a long-standing commitment to delivering quality services, this leading HVAC contractor has played a pivotal role in ensuring Aledo homes remain comfortable every season. Beco Air and Heat offers comprehensive HVAC services catering to diverse heating

Corporate Training Market to grow by USD 43.86 billion (2025-2029), driven by cost-effective e-learning modules, report highlights AI-driven transformation – Technavio

Report with market evolution powered by AI – The global corporate training marketsize is estimated to grow by USD 43.86 billion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of 7.8% during the forecast period. Emergence of cost-effective e-learning training modulesis driving market growth,with a trend towardsemergence of iot

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pacira

(NASDAQ:PCRX), Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Pacira To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Pacira between August 2, 2023 and August 8, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner

REGN INVESTOR NOTICE: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit

The law firm ofRobbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) securities between November 2, 2023 and October 30, 2024, inclusive (the “Class Period”), have until Monday, March 10, 2025 to seek appointment as lead plaintiff of the Regeneron class action lawsuit. Captioned Radtke v. Regeneron

Statement by Minister Khera on the Lunar New Year

The Government of Canada celebrates the Lunar New Year As we enter the Lunar New Year, I extend my warmest greetings to everyone celebrating in Canada and around the world, including the Chinese, Korean and Vietnamese communities. Today, we welcome the Year of the Snake, making its return after a 12-year cycle. Also known as

Class Action Filed Against Marqeta, Inc. (MQ) Seeking Recovery for Investors – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / January 29, 2025 / If you suffered a loss on your Marqeta, Inc. (NASDAQ:MQ) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/marqeta-inc-lawsuit-submission-form?prid=125833&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Kyverna Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 7, 2025 to Discuss Your Rights – KYTX

NEW YORK, NY / ACCESS Newswire / January 29, 2025 / If you suffered a loss on your Kyverna Therapeutics, Inc. (NASDAQ:KYTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/kyverna-therapeutics-inc-lawsuit-submission-form?prid=125830&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Scroll to Top